Rainier Therapeutics Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
Rainier Therapeutics General Information
Description
Developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer. The company's technology uses Vofatamab, a human monoclonal antibody that targets and specifically blocks the activity of FGFR3 (fibroblast growth factor receptor 3), enabling medical practitioners to treat patients with early-stage and metastatic bladder cancer effectively.
Contact Information
Website
www.rainierrx.comCorporate Office
- 1040 Davis Street
- Suite 202
- San Leandro, CA 94577
- United States
Corporate Office
- 1040 Davis Street
- Suite 202
- San Leandro, CA 94577
- United States
Rainier Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 04-Mar-2021 | Completed | Out of Business | |||
| 5. Later Stage VC | 23-Jul-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 30-Apr-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A2) | 04-Jun-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | $16M | $19M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 28-Dec-2012 | $3M | $3M | Completed | Generating Revenue |
Rainier Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Rainier Therapeutics Comparisons
Industry
Financing
Details
Rainier Therapeutics Competitors (65)
One of Rainier Therapeutics’s 65 competitors is Cogent Biosciences, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cogent Biosciences | Formerly VC-backed | Waltham, MA | ||||
| Xenetic Biosciences | Corporation | Framingham, MA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA |
Rainier Therapeutics Patents
Rainier Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018145120-A1 | Methods, compositions, and kits for treatment of cancer | Inactive | 06-Feb-2017 | ||
| WO-2016134234-A1 | Methods, compositions, and kits for treatment of cancer | Inactive | 19-Feb-2015 |
Rainier Therapeutics Signals
Rainier Therapeutics FAQs
-
When was Rainier Therapeutics founded?
Rainier Therapeutics was founded in 2010.
-
Where is Rainier Therapeutics headquartered?
Rainier Therapeutics is headquartered in San Leandro, CA.
-
What is the size of Rainier Therapeutics?
Rainier Therapeutics has 11 total employees.
-
What industry is Rainier Therapeutics in?
Rainier Therapeutics’s primary industry is Drug Discovery.
-
Is Rainier Therapeutics a private or public company?
Rainier Therapeutics is a Private company.
-
What is Rainier Therapeutics’s current revenue?
The current revenue for Rainier Therapeutics is .
-
How much funding has Rainier Therapeutics raised over time?
Rainier Therapeutics has raised $99M.
-
Who are Rainier Therapeutics’s competitors?
Cogent Biosciences, Xenetic Biosciences, Kite Pharma, Inovio Pharmaceuticals, and Meditope Biosciences are some of the 65 competitors of Rainier Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process